Cerus Corp is a leading healthcare company in the United States, specializing in biomedical products for blood transfusion safety. Their INTERCEPT Blood System effectively minimizes the risk of transfusion-transmitted infections by targeting pathogens like viruses, bacteria, and parasites. With an impressive ESG score of 19.7 and a low risk rating, Cerus Corp operates solely in the Blood safety sector, serving customers in various regions worldwide, including Europe, the Middle East, and CIS countries.